| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | OVOL1 SALL3 HOXC12 SPIB EGR2 ZNF341 RORA IRF5 ASCL3 PGR PROP1 | 5.08e-04 | 1412 | 49 | 11 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.50e-03 | 1459 | 49 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.51e-03 | 566 | 49 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | UDP-galactosyltransferase activity | 2.79e-03 | 32 | 49 | 2 | GO:0035250 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.94e-03 | 1244 | 49 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.19e-03 | 120 | 49 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 3.33e-03 | 35 | 49 | 2 | GO:0008378 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 3.39e-03 | 1271 | 49 | 9 | GO:0000987 | |
| GeneOntologyBiologicalProcess | cell cycle switching | 3.17e-05 | 4 | 48 | 2 | GO:0060184 | |
| GeneOntologyBiologicalProcess | cell cycle switching, mitotic to meiotic cell cycle | 3.17e-05 | 4 | 48 | 2 | GO:0051728 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 8.69e-05 | 37 | 48 | 3 | GO:0051446 | |
| Domain | DVL-1 | 7.31e-06 | 2 | 51 | 2 | IPR008340 | |
| Domain | Dishevelled | 4.37e-05 | 4 | 51 | 2 | PF02377 | |
| Domain | Dishevelled_protein_dom | 4.37e-05 | 4 | 51 | 2 | IPR003351 | |
| Domain | Dishevelled_fam | 4.37e-05 | 4 | 51 | 2 | IPR008339 | |
| Domain | DIX | 1.52e-04 | 7 | 51 | 2 | IPR001158 | |
| Domain | DIX | 1.52e-04 | 7 | 51 | 2 | PS50841 | |
| Domain | DAX | 1.52e-04 | 7 | 51 | 2 | SM00021 | |
| Domain | DIX | 1.52e-04 | 7 | 51 | 2 | PF00778 | |
| Domain | Glyco_hormone_CN | 7.50e-04 | 15 | 51 | 2 | IPR006208 | |
| Domain | Cys_knot | 7.50e-04 | 15 | 51 | 2 | PF00007 | |
| Domain | DEP | 1.63e-03 | 22 | 51 | 2 | PF00610 | |
| Domain | DEP | 1.63e-03 | 22 | 51 | 2 | SM00049 | |
| Domain | DEP | 1.63e-03 | 22 | 51 | 2 | PS50186 | |
| Domain | DEP_dom | 1.78e-03 | 23 | 51 | 2 | IPR000591 | |
| Domain | WHTH_DNA-bd_dom | 4.26e-03 | 242 | 51 | 4 | IPR011991 | |
| Domain | zf-C4 | 7.01e-03 | 46 | 51 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 7.01e-03 | 46 | 51 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 7.01e-03 | 46 | 51 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 7.01e-03 | 46 | 51 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 7.01e-03 | 46 | 51 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 7.01e-03 | 46 | 51 | 2 | PS51030 | |
| Domain | - | 7.31e-03 | 47 | 51 | 2 | 1.10.565.10 | |
| Domain | HOLI | 7.61e-03 | 48 | 51 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 7.61e-03 | 48 | 51 | 2 | IPR000536 | |
| Domain | Hormone_recep | 7.61e-03 | 48 | 51 | 2 | PF00104 | |
| Domain | - | 8.88e-03 | 52 | 51 | 2 | 2.60.120.290 | |
| Domain | VWA | 1.02e-02 | 56 | 51 | 2 | PF00092 | |
| Domain | - | 1.06e-02 | 57 | 51 | 2 | 3.30.50.10 | |
| Domain | CUB_dom | 1.06e-02 | 57 | 51 | 2 | IPR000859 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8644734 | ||
| Pubmed | Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. | 6.32e-06 | 3 | 51 | 2 | 22610141 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 8817329 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 1.26e-05 | 4 | 51 | 2 | 9192851 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 25891077 | ||
| Pubmed | A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis. | 1.26e-05 | 4 | 51 | 2 | 18268344 | |
| Pubmed | Non-canonical Wnt signaling induces ubiquitination and degradation of Syndecan4. | 1.26e-05 | 4 | 51 | 2 | 20639201 | |
| Pubmed | Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. | 2.10e-05 | 5 | 51 | 2 | 17360658 | |
| Pubmed | Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. | 2.10e-05 | 5 | 51 | 2 | 17275788 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 23213237 | ||
| Pubmed | 2.78e-05 | 118 | 51 | 4 | 16971476 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 26468541 | ||
| Pubmed | USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling. | 4.41e-05 | 7 | 51 | 2 | 33786993 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 23300459 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 19643732 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 23770228 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 19741118 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 19798431 | ||
| Pubmed | Mit1/Lb9 and Copg2, new members of mouse imprinted genes closely linked to Peg1/Mest(1). | 1.38e-04 | 12 | 51 | 2 | 10788617 | |
| Pubmed | Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. | 1.38e-04 | 12 | 51 | 2 | 20639880 | |
| Pubmed | IL-7Rα glutamylation and activation of transcription factor Sall3 promote group 3 ILC development. | 1.38e-04 | 12 | 51 | 2 | 28794449 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.41e-04 | 544 | 51 | 6 | 28473536 | |
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 19652017 | ||
| Pubmed | Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. | 1.90e-04 | 14 | 51 | 2 | 21820332 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.92e-04 | 1105 | 51 | 8 | 35748872 | |
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 20848568 | ||
| Pubmed | The expression pattern of nuclear receptors during cerebellar development. | 2.83e-04 | 17 | 51 | 2 | 17205580 | |
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 21082674 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.44e-04 | 908 | 51 | 7 | 19274049 | |
| Pubmed | Chato, a KRAB zinc-finger protein, regulates convergent extension in the mouse embryo. | 4.35e-04 | 21 | 51 | 2 | 18701545 | |
| Pubmed | 6.19e-04 | 25 | 51 | 2 | 23042114 | ||
| Pubmed | Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. | 6.70e-04 | 26 | 51 | 2 | 21399635 | |
| Pubmed | 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. | 8.93e-04 | 30 | 51 | 2 | 16306228 | |
| Pubmed | 1.02e-03 | 32 | 51 | 2 | 16516881 | ||
| Pubmed | 1.12e-03 | 536 | 51 | 5 | 12690205 | ||
| Cytoband | 7q32 | 3.29e-04 | 24 | 51 | 2 | 7q32 | |
| Cytoband | 1p36.12 | 8.73e-04 | 39 | 51 | 2 | 1p36.12 | |
| Cytoband | 19q13.3 | 3.80e-03 | 82 | 51 | 2 | 19q13.3 | |
| GeneFamily | Nuclear hormone receptors | 3.18e-03 | 49 | 31 | 2 | 71 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.26e-07 | 151 | 51 | 5 | 7e5e35ce601ca3d3722063566e89664909171b8d | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.91e-06 | 179 | 51 | 5 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-06 | 180 | 51 | 5 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-06 | 180 | 51 | 5 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 184 | 51 | 5 | 5b0695b1fbc8e4230f8f0669373ea10af82a0130 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 184 | 51 | 5 | 6485d0d34bdab337b747c0ea2d75e8fad8486b4d | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.55e-05 | 162 | 51 | 4 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.55e-05 | 162 | 51 | 4 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.55e-05 | 162 | 51 | 4 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 168 | 51 | 4 | 29a6c3ba69e03ccb19efb8ac177b9a162dc1ea43 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 168 | 51 | 4 | 4297be958a4754677df7cf73feba19b0d76f1b4a | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 176 | 51 | 4 | 24eedbbb406d788630bb16678cceef4492d3999c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.01e-05 | 177 | 51 | 4 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Erythrophagocytic_macrophages|Lung / Manually curated celltypes from each tissue | 5.12e-05 | 178 | 51 | 4 | b63cee443cc1b7416112bf610d7c9d41e4fa37ed | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-05 | 181 | 51 | 4 | 1d3d1b5a6efe9cedd03b7e0b5684df97f0246729 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-05 | 181 | 51 | 4 | 0069e8308de932df43660bbe926637c57b8bf7f6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-05 | 184 | 51 | 4 | 95cf125127658c4c04445c61809d1aed21ee1f83 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-05 | 191 | 51 | 4 | 6a8b0987e75456a257954288206da0032605ff2a | |
| ToppCell | CV-Healthy-6|CV / Virus stimulation, Condition and Cluster | 7.01e-05 | 193 | 51 | 4 | 1e285c31823d3e1a18d8c01748cc3604f400c954 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.44e-05 | 196 | 51 | 4 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 7.44e-05 | 196 | 51 | 4 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.89e-05 | 199 | 51 | 4 | eb2d1b7e875c5bf833e7a80b43282e12893c34e9 | |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 3.63e-06 | 198 | 48 | 6 | 3904_UP | |
| Drug | MGA-100 | 7.02e-06 | 18 | 48 | 3 | CID000018020 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 2.80e-05 | 5 | 50 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | eosinophil percentage of leukocytes | 3.38e-05 | 746 | 50 | 8 | EFO_0007991 | |
| Disease | sclerosing cholangitis | 1.94e-04 | 66 | 50 | 3 | EFO_0004268 | |
| Disease | intraocular pressure measurement | 2.14e-04 | 509 | 50 | 6 | EFO_0004695 | |
| Disease | skin pigmentation | 2.22e-04 | 69 | 50 | 3 | EFO_0003784 | |
| Disease | Proteinuria | 2.91e-04 | 15 | 50 | 2 | HP_0000093 | |
| Disease | breast carcinoma | 2.91e-04 | 1019 | 50 | 8 | EFO_0000305 | |
| Disease | age of onset of childhood onset asthma | 5.17e-04 | 92 | 50 | 3 | OBA_2001015 | |
| Disease | lower face morphology measurement | 8.47e-04 | 109 | 50 | 3 | EFO_0010948 | |
| Disease | adult onset asthma | 1.07e-03 | 118 | 50 | 3 | EFO_1002011 | |
| Disease | asthma, Eczema, allergic rhinitis | 1.15e-03 | 121 | 50 | 3 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | Eczema | 1.88e-03 | 310 | 50 | 4 | HP_0000964 | |
| Disease | respiratory system disease | 1.92e-03 | 145 | 50 | 3 | EFO_0000684 | |
| Disease | biliary liver cirrhosis | 2.54e-03 | 44 | 50 | 2 | EFO_0004267 | |
| Disease | Primary biliary cirrhosis | 2.90e-03 | 47 | 50 | 2 | C0008312 | |
| Disease | myocardial infarction | 2.92e-03 | 350 | 50 | 4 | EFO_0000612 | |
| Disease | eosinophil count | 3.33e-03 | 1488 | 50 | 8 | EFO_0004842 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYPTPSGQYVCSPLP | 546 | Q86US8 | |
| PCYGLEPGPATPDFY | 161 | Q9HB09 | |
| ASYPTNPCFPFSVPE | 536 | Q9HC96 | |
| CSMPPPFSYNGTYRP | 736 | P19801 | |
| PPDYYPECQSQPAVS | 256 | Q8N7E2 | |
| SPPEVERCTYPFYPG | 361 | Q8TBY0 | |
| PPPYSGCAGDLYQDP | 171 | P11161 | |
| TPGPCAYQVVSPGVY | 181 | A8MYP8 | |
| VCPSGFYPYPVQTRT | 61 | P00751 | |
| PSAEPCNGYPQPYLG | 56 | P31275 | |
| PCAPGSYLQFYEGPP | 106 | Q5SZI1 | |
| SPCLPESYPYGSPQE | 606 | Q9HCH0 | |
| YPGPTVFPDYTNPVC | 441 | Q2M2H8 | |
| YPQSVPIPFCGDYIG | 861 | Q9UBC5 | |
| PPPPPYQNQSTCAVY | 5521 | P98088 | |
| PPQPYKIYEVCSNGP | 111 | Q13568 | |
| YVPVSLGFCPPQPYR | 31 | O14753 | |
| TPVAVGDFPDCAYPP | 351 | P06401 | |
| SPGYPDIYPPNVECV | 1751 | O60494 | |
| VPPPSYFATFYSCTP | 146 | Q15884 | |
| VPLYPTDCPPSYEAV | 276 | P81408 | |
| PYVLYPGFQPVPVTA | 1331 | Q711Q0 | |
| LPENFTYSPYLPCPE | 96 | Q9UBX8 | |
| LPNCAPGVDPFYTYP | 96 | Q86YW7 | |
| VTPQSPECYPPSYPS | 101 | Q53EP0 | |
| YSPPGYMPNTEECPV | 2341 | A8TX70 | |
| NYSEPCPFSFPMPYP | 66 | Q9NQ33 | |
| CPFSFPMPYPNYRGC | 71 | Q9NQ33 | |
| PVPPPPTNFNFCYDC | 701 | Q96BJ8 | |
| PAPSLPYNQPGICYT | 691 | Q9UBF2 | |
| PPCFPPAYQDPGFSY | 546 | O14640 | |
| PPCFPPAYQDPGFSY | 521 | P54792 | |
| VPPQLFPGSAYPVYC | 266 | Q6ZMB0 | |
| PGYPLQLQPCTAYVP | 166 | Q99946 | |
| FGEEPPAPQYTGPFC | 161 | O75995 | |
| PYPVPEYLDNVPTCS | 481 | Q9BXA9 | |
| PFYPSQPVYQSAPII | 111 | O43432 | |
| FPYAYVTERGPCFPP | 956 | Q8ND04 | |
| PVVSYPPFPGNEANY | 466 | Q9H0K4 | |
| GLPGQAPPCYAPTYF | 301 | Q8WV15 | |
| APPCYAPTYFPPGEK | 306 | Q8WV15 | |
| SPAPDYPTPCQYPVD | 856 | Q9H0K1 | |
| PQAAQLCYEPPTYSP | 71 | Q01892 | |
| SSPPGPYHQEPYVCK | 181 | Q9Y478 | |
| PSPCYGCGFPVYPTR | 171 | Q9NUL5 | |
| AYCNTPPPPYEQVVK | 156 | Q96AW1 | |
| QCVEPPVYPTPTVYS | 251 | Q9BYN7 | |
| PEPICDYTPASGFFP | 241 | P35398 | |
| MPTLPPYQPASGLCY | 291 | Q6NTF9 | |
| SCPIPDGPFYADPNY | 211 | Q96A28 | |
| TACPYSYAAPPPPVT | 151 | O75360 | |
| RQEICPASYPSPPGY | 361 | Q658L1 | |
| PPPSYDPDYIQCPYC | 111 | Q96GY0 | |
| VQYTLTEEPPPGCYP | 806 | Q9ULT6 | |
| TELLVYYPPPSAPQC | 216 | Q8N0Z9 | |
| TTCPTAYYQPAPQPG | 26 | A8MV65 | |
| LLGVPPQPAYFFCPS | 71 | Q14679 |